{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T20:47:13Z","timestamp":1762375633249},"reference-count":20,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.ijrobp.2012.04.045","type":"journal-article","created":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T13:31:45Z","timestamp":1343827905000},"page":"e385-e392","source":"Crossref","is-referenced-by-count":21,"title":["The Impact of Local and Regional Disease Extent on Overall Survival in Patients With Advanced Stage IIIB\/IV Non-Small Cell Lung Carcinoma"],"prefix":"10.1016","volume":"84","author":[{"given":"Daniel S.","family":"Higginson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald C.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregg","family":"Tracton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David E.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Halle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julian G.","family":"Rosenman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mihaela","family":"Stefanescu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erica","family":"Pham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark A.","family":"Socinski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence B.","family":"Marks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2012.04.045_bib1","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1136\/thx.2003.020164","article-title":"Chemotherapy versus supportive care in advanced non-small cell lung cancer: improved survival without detriment to quality of life","volume":"59","author":"Spiro","year":"2004","journal-title":"Thorax"},{"issue":"suppl 1","key":"10.1016\/j.ijrobp.2012.04.045_bib2","doi-asserted-by":"crossref","first-page":"S147","DOI":"10.1016\/0169-5002(95)00430-9","article-title":"Meta-analysis of randomised trials of systemic chemotherapy versus supportive treatment in non-resectable non-small cell lung cancer","volume":"12","author":"Souquet","year":"1995","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ijrobp.2012.04.045_bib3","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/JTO.0b013e31816de2b8","article-title":"The impact of additional prognostic factors on survival and their relationship with the anatomical extent of disease expressed by the 6th Edition of the TNM Classification of Malignant Tumors and the proposals for the 7th Edition","volume":"3","author":"Sculier","year":"2008","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ijrobp.2012.04.045_bib4","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/cncr.24813","article-title":"Pack-years of cigarette smoking as a prognostic factor in patients with stage IIIB\/IV nonsmall cell lung cancer","volume":"116","author":"Janjigian","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2012.04.045_bib5","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/cncr.22049","article-title":"A prognostic model for advanced stage nonsmall cell lung cancer. Pooled analysis of North Central Cancer Treatment Group trials","volume":"107","author":"Mandrekar","year":"2006","journal-title":"Cancer"},{"issue":"suppl","key":"10.1016\/j.ijrobp.2012.04.045_bib6","first-page":"15s","article-title":"Randomized phase II trial of erlotinib (E) alone or in combination with carboplatin\/paclitaxel (CP) in never or light former smokers with advanced lung adenocarcinoma: CALGB 30406 [abstract]","volume":"28","author":"Janne","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2012.04.045_bib7","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/annonc\/mdp352","article-title":"A randomized, phase III multicenter trial of gemcitabine in combination with carboplatin or paclitaxel versus paclitaxel plus carboplatin in patients with advanced or metastatic non-small-cell lung cancer","volume":"21","author":"Treat","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2012.04.045_bib8","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3109\/07357900903286958","article-title":"A multicenter phase II trial of carboplatin and cetuximab for treatment of advanced nonsmall cell lung cancer","volume":"28","author":"Stinchcombe","year":"2010","journal-title":"Cancer Invest"},{"key":"10.1016\/j.ijrobp.2012.04.045_bib9","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1093\/annonc\/mdj016","article-title":"A randomized phase II trial comparing every 3-weeks carboplatin\/paclitaxel with every 3-weeks carboplatin and weekly paclitaxel in advanced non-small cell lung cancer","volume":"17","author":"Socinski","year":"2006","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2012.04.045_bib10","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1093\/annonc\/mdn745","article-title":"A randomized, phase II trial of two dose schedules of carboplatin\/paclitaxel\/cetuximab in stage IIIB\/IV non-small-cell lung cancer (NSCLC)","volume":"20","author":"Socinski","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2012.04.045_bib11","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1097\/JTO.0b013e3181fd42eb","article-title":"Randomized, phase II trial of pemetrexed and carboplatin with or without enzastaurin versus docetaxel and carboplatin as first-line treatment of patients with stage IIIB\/IV non-small cell lung cancer","volume":"5","author":"Socinski","year":"2010","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ijrobp.2012.04.045_bib12","doi-asserted-by":"crossref","first-page":"5255","DOI":"10.1200\/JCO.2009.22.0616","article-title":"Safety of bevacizumab in patients with non-small-cell lung cancer and brain metastases","volume":"27","author":"Socinski","year":"2009","journal-title":"J Clin Oncol"},{"issue":"suppl","key":"10.1016\/j.ijrobp.2012.04.045_bib13","first-page":"18S","article-title":"Results of a randomized, phase III trial of nab-paclitaxel (nab-P) and carboplatin (C) compared with cremophor-based paclitaxel (P) and carboplatin as first-line therapy in advanced non-small cell lung cancer (NSCLC) [abstract]","volume":"28","author":"Socinski","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2012.04.045_bib14","series-title":"American Joint Committee on Cancer: AJCC Cancer Staging Manual","author":"Edge","year":"2009"},{"key":"10.1016\/j.ijrobp.2012.04.045_bib15","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1002\/cncr.23679","article-title":"Never-smoking nonsmall cell lung cancer as a separate entity: clinicopathologic features and survival","volume":"113","author":"Yano","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2012.04.045_bib16","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1002\/cncr.21884","article-title":"Smoking affects treatment outcome in patients with advanced nonsmall cell lung cancer","volume":"106","author":"Tsao","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2012.04.045_bib17","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/S0140-6736(09)61497-5","article-title":"Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study","volume":"374","author":"Ciuleanu","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2012.04.045_bib18","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S1470-2045(10)70112-1","article-title":"Erlotinib as maintenance treatment in advanced non-small-cell lung cancer: a multicentre, randomised, placebo-controlled phase 3 study","volume":"11","author":"Cappuzzo","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2012.04.045_bib19","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1200\/JCO.2008.17.1405","article-title":"Phase III study of immediate compared with delayed docetaxel after front-line therapy with gemcitabine plus carboplatin in advanced non-small-cell lung cancer","volume":"27","author":"Fidias","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ijrobp.2012.04.045_bib20","first-page":"649","article-title":"The need for third-line treatment in non-small cell lung cancer: an overview of new options","volume":"31","author":"Syrigos","year":"2011","journal-title":"Anticancer Res"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301612006426?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301612006426?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,21]],"date-time":"2018-11-21T19:30:01Z","timestamp":1542828601000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301612006426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0360301612006426"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2012.04.045","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}